Implantable defibrillators versus medical therapy for cardiac channelopathies

Pharmacology, Toxicology and Pharmaceutical Science

• Combination Therapy 100%
• Placebo 100%
• Adverse Event 100%
• All Cause Mortality 100%
• Antiarrhythmic Agent 100%
• Cardiovascular Mortality 100%
• Sudden Cardiac Death 100%
• Channelopathy 100%
• Long QT Syndrome 100%
• Brugada Syndrome 100%
• Catecholaminergic Polymorphic Ventricular Tachycardia 100%
• Cardiac Channelopathy 100%
• Short QT Syndrome 100%

Keyphrases

• Medical Therapy 100%
• Implantable Defibrillator 100%
• Cardiac Channelopathies 100%
• Usual Care 50%
• Placebo 50%
• Adverse Events 50%
• Risk Reduction 50%
• All-cause Mortality 50%
• Antiarrhythmic Drugs 50%
• Cardiovascular Mortality 50%
• Sudden Cardiac Death 50%
• Brugada Syndrome 50%
• Short QT Syndrome 50%
• Congential 50%
• Mortality Event 50%
• Congenital Long QT Syndrome 50%
• Catecholaminergic Polymorphic Ventricular Tachycardia 50%